Navigation Links
Cepheid Reports Fourth Quarter and Full Year 2011 Results
Date:1/26/2012

in spite of continuing tight capital availability in the US and Europe.  In 2012, we will continue to invest aggressively in Xpert® test menu expansion to enable the benefits of our system to be realized in broader segments of the market. We expect to further extend our technology leadership and strong growth momentum in the quarters and years ahead."

Operational Overview

  • Fourth quarter of 2011 Clinical sales of $68.9 million grew 39% from $49.5 million in the fourth quarter of 2010, and total fourth quarter of 2011 product sales of $76.9 million grew 37% from the same quarter a year ago.  For the year ended December 31, 2011, total Clinical sales of $236.0 million grew 36% from $173.8 million reported for the same period a year ago.  
  • By industry, product sales were, in millions:

  • Three Months Ended December 31,Full Year Ended December 31,20112010Change20112010ChangeClinical Systems

    $
    9.9$
    2.758%$
    58.6$
    42.538%Clinical Reagents

    49.036.833%177.4131.335%Total Clinical 68.949.539%236.0173.836%Non-Clinical

    8.06.719%29.533.1-11%Total Product Sales$
    76.9$
    56.237%$
    265.5$
    206.928%

  • By geography, product sales were, in millions:
  • Three Months Ended December 31,Full Year Ended December 31,20112010Change20112010ChangeNorth AmericaClinical

    $
    46.4$
    38.521%$
    7.9$
    37.322%Other

    7.25.433%25.027.3-8%Total North America53.643.922%192.9164.617%InternationalClinical

    22.511.0105%68.136.587%Other

    0.81.3-38%4.55.8-22%Total International23.312.389%72.642.372%Total Product Sales$
    76.9$
    56.237%$
    265.5$
    206.928%

  • During the fourth quarter of 2011, Cepheid placed a total of 175 GeneXpert systems in its commercial Clinical business.  Additionally, the Company placed a total of 181 GeneXpert systems as part of its High Burden Developing Country (HBDC) program.  For the year ended December 31, 2011, Cepheid placed a to
    '/>"/>

  • SOURCE Cepheid
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. Cepheid Welcomes Senior Vice President of Human Resources
    2. Cepheid Receives FDA Clearance for Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain
    3. Cepheid Schedules 2010 Third Quarter Financial Results Announcement and Webcast
    4. Cepheid to Webcast Upcoming Financial Presentations
    5. Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations
    6. Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast
    7. Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast
    8. Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
    9. Cepheid Reports 2009 First Quarter Results
    10. Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast
    11. Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)... Research and Markets has announced the addition ... Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - ... The global molecular biology enzymes market was ... to grow at a CAGR of 13.74% to reach ... reagents find applications in a large number of fields ...
    (Date:8/22/2014)... 22, 2014 “Our nation's healthcare ... a national disgrace. Furthermore, every governmental and professional ... current, deplorable state of unorganized dysfunction shares in ... to merely serve as a device to use ... colossal failure(s) that have accumulated through the years ...
    (Date:8/21/2014)... including DESY scientists has observed tiny quantum vortices in ... the journal Science that the exotic vortices ... It is the first time that the quantum vortices, ... what is known as superfluid helium, have been detected ... says Andrey Vilesov of the University of Southern California, ...
    (Date:8/21/2014)... , Aug. 21, 2014 Telomere ... of their Nutraceutical "TELO-20 for Dogs" with ... Telomere-lengthening supplement in the world for dogs. Telomeres ... every chromosome in the body. A wealth of ... experts in Telomere Science and Aging, including Nobel ...
    Breaking Biology Technology:Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 35 Great Mistakes in Healthcare and How to Fix Them by Dr. Ira Williams 2Scientists observe quantum vortices in cold helium droplets 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 3
    ... adds advanced cholesterol testing capabilities, BIRMINGHAM, ... company, today announced that its VAP(R) Cholesterol ... released health,assessment, BiophysicalCheck., The announcement means ... ability to,identify far more areas of risk ...
    ... (Nasdaq: BCRX ) today announced that its ... Thursday, August 7, 2008. Following,the release, BioCryst will ... a.m.,Eastern Time to discuss the financial results and ... will be led by Jon P. Stonehouse, BioCryst,s,Chief ...
    ... 31 NeoStem, Inc. (Amex: NBS ),has announced ... cell,collection centers. Through a development agreement with Stem Collect ... Monica based medical,practice., The Los Angeles area is ... a large concentration of physician practices,and hospitals offering a ...
    Cached Biology Technology:VAP(R) Cholesterol Test Bolsters Biophysical(R) Health Assessment 2VAP(R) Cholesterol Test Bolsters Biophysical(R) Health Assessment 3BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008 2BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008 3NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist 2NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist 3
    (Date:8/21/2014)... A new study of American singles found that ... the highest orgasm rates. On average, men experience ... sexual orientation making little difference. For women, however, ... experience orgasm 62.9 percent of the time during ... pattern varies with women,s sexual orientation, with lesbian ...
    (Date:8/21/2014)... they are the ultimate source of all organic matter ... on algae, too, to suck up climate-warming carbon dioxide ... of the ocean. Now, by using a combination of ... that viruses infecting those algae are driving the life-and-death ... stays essentially the same, and this has important implications ...
    (Date:8/21/2014)... A landmark study aimed at improving the food intake, ... long-term care homes is among three projects at the ... grants from the Canadian Institutes of Health Research (CIHR). ... Applied Health Sciences at Waterloo, and a Schlegel research ... two years to investigate why many Canadians living in ...
    Breaking Biology News(10 mins):Orgasm rates for single women less predictable than men's, vary by sexual orientation 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 3Orgasm rates for single women less predictable than men's, vary by sexual orientation 4Viruses take down massive algal blooms, with big implications for climate 2Grants will fund landmark aging research at Waterloo 2
    ... synthesising chemicals from plant material could produce liquid fuel for ... if the infrastructure is set up in the right way, ... Biofuels, Bioproducts & Biorefining . Developed by scientists at ... known as bioliq, and is able to produce a range ...
    ... strains of methicillin-resistant Staphylococcus aureus , commonly known ... exposing them to a wavelength of blue light, in ... paper published online ahead of print in Photomedicine ... the April 2009 issue (Volume 27, Number 2) of ...
    ... some allergic reactions progress quickly and may even become ... 2009 issue of the Journal of Leukocyte Biology ... the answer. In the report, scientists from Queen,s University ... show for the first time that eotaxin, a chemical ...
    Cached Biology News:Novel technology could produce biofuel for around 0.50 a liter ($2.49 a gallon) 2Blue light destroys antibiotic-resistant staph infection 2New discovery may lead to new class of allergy drugs 2
    Monoclonal Anti-Gα o purified immunoglobulin buffered aqueous solution Solution in phosphate buffered saline pH 7.4, containing 0.08% sodium azide. partially purified bovine brain Gα O ...
    Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
    ... 9-Octadecenoyl-N-hydroxylamide Oleoyl-N-hydroxylamide White solid. PROTECT ... potent inhibitor of MMP-2 that acts in ... 1.7 μM). Purity: ≥98% by TLC. ... in solution, reconstitute just prior to use. ...
    MAb to Vasopressin Preservative: NaN3...
    Biology Products: